Man Group PLC Acumen Pharmaceuticals, Inc. Transaction History
Man Group PLC
- $37.6 Billion
- Q2 2024
A detailed history of Man Group PLC transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Man Group PLC holds 105,777 shares of ABOS stock, worth $267,615. This represents 0.0% of its overall portfolio holdings.
Number of Shares
105,777
Previous 187,585
43.61%
Holding current value
$267,615
Previous $759,000
66.4%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ABOS
# of Institutions
86Shares Held
42.4MCall Options Held
239KPut Options Held
65.9K-
Ra Capital Management, L.P. Boston, MA14.9MShares$37.8 Million0.54% of portfolio
-
Franklin Resources Inc San Mateo, CA3.55MShares$8.98 Million0.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$8.65 Million4.37% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.3MShares$5.82 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$5.46 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $102M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...